Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition associated with increased mortality among patients with cancer. CHIP mutations with high variant-allele ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors ...

Their preclinical studies found that blocking activity of EPO converts formerly “cold” – or immune-resistant – liver tumors in mice into “hot” tumors teeming with cancer-fighting ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results. By Gina Kolata When a person ...

The reality alum has shared a positive update in her ongoing cancer struggle, saying that all her tumors have “shrunk or disappeared” Teddi Mellencamp/Instagram Real Housewives of Beverly ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from ...

The TV personality and daughter of rock singer John Mellencamp, who revealed in February that several tumors were found on her brain, shared an encouraging update on her cancer recovery in an ...

Government cuts are “slowing down” further research, a researcher said. A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

A new report on cancer in the U.S. shows a steady decline in overall deaths from 2001 through 2022. The rate of diagnoses among men fell from 2001 through 2013 and then stabilized through 2021 ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

While the results are promising, the study was conducted at a single hospital -- Memorial Sloan Kettering Cancer Center in New York City -- and some patients have not been followed long enough to ...